PlainRecalls
FDA Drug Low Class III Terminated

Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61

Reported: May 17, 2023 Initiated: April 24, 2023 #D-0570-2023

Product Description

Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61

Reason for Recall

Product mixup: one foreign tablet found in product.

Details

Recalling Firm
The Harvard Drug Group
Units Affected
3984 cartons
Distribution
USA Nationwide
Location
La Vergne, TN

Frequently Asked Questions

What product was recalled?
Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61. Recalled by The Harvard Drug Group. Units affected: 3984 cartons.
Why was this product recalled?
Product mixup: one foreign tablet found in product.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 17, 2023. Severity: Low. Recall number: D-0570-2023.